DCGI approves emergency use authorisation of Russian vaccine, Sputnik V

Search

DCGI approves emergency use authorisation of Russian vaccine, Sputnik V

The efficacy of Sputnik V is 91.6 per cent as confirmed by the data published in the Lancet, one of the world's oldest and most respected medical journals; it is one of only three vaccines in the world with an efficacy of over 90 per cent; Sputnik V provides full protection against severe cases of COVID-19.